These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 157893)

  • 1. Percutaneous absorption of clioquinol (Vioform).
    Degen PH; Moppert J; Schmid K; Weirich EG
    Dermatologica; 1979; 159(4):295-301. PubMed ID: 157893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous absorption of chlorquinaldol (Sterosan).
    Degen PH; Moppert J; Schmid K; Weirich EG
    Dermatologica; 1979; 159(3):239-44. PubMed ID: 478062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous absorption of iodochlorhydroxyquin in humans.
    Stohs SJ; Ezzedeen FW; Anderson AK; Baldwin JN; Makoid MC
    J Invest Dermatol; 1984 Feb; 82(2):195-8. PubMed ID: 6229586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption of 8-hydroxyquinolines through the human skin.
    Fischer T; Fagerlund C; Hartvig P
    Acta Derm Venereol; 1978; 58(5):407-11. PubMed ID: 82350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial effectiveness of Locacorten-Vioform cream in Secondary infections of common dermatoses.
    Konopka EA; Kimble EF; Zogans HC; Heyman H
    Dermatologica; 1975; 151(1):1-8. PubMed ID: 128475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [THE TOPICAL USE OF VIOFORM-HYDROCORTISONE CREAM IN ALLERGY].
    VIZZINI AA
    Folha Med; 1964 Feb; 48():61-6. PubMed ID: 14271196
    [No Abstract]   [Full Text] [Related]  

  • 7. [The use of locacorten-vioform ointment with xylocaine hydrochloride in the treatment of painful alveolitis].
    Lewandowski B
    Czas Stomatol; 1978 Jan; 31(1):51-4. PubMed ID: 146597
    [No Abstract]   [Full Text] [Related]  

  • 8. Enterohepatic circulation of clioquinol in the rat.
    Kotaki H; Yamamura Y; Tanimura Y; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1984 Jun; 7(6):420-5. PubMed ID: 6237189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of Locacorten-Vioform and clotrimazole in otomycosis: A systematic review and one-way meta-analysis.
    Herasym K; Bonaparte JP; Kilty S
    Laryngoscope; 2016 Jun; 126(6):1411-9. PubMed ID: 26600419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience with utilization of locacorten-vioform ointment in dermatology].
    Skripkin IuK; Sharapova GIa; Somov BA; Butov IuS; Khamaganova AV
    Vestn Dermatol Venerol; 1968 Dec; 42(12):67-8. PubMed ID: 4242971
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary irritant dermatitis from topical clioquinol.
    Kero M; Hannuksela M; Sothman A
    Contact Dermatitis; 1979 Mar; 5(2):115-7. PubMed ID: 157250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous absorption of amorolfine following a single topical application of an amorolfine cream formulation.
    Roncari G; Ponelle C; Zumbrunnen R; Guenzi A; Dingemanse J; Jonkman JH
    Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():33-6. PubMed ID: 1458662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study on the topical application of "locacorten-vioform" for rosacea and dysseborrhoeic dermatitis in a paste, ointment and cream BASE.
    Belisario JC
    Med J Aust; 1967 Mar; 1(11):545-6. PubMed ID: 4225669
    [No Abstract]   [Full Text] [Related]  

  • 14. Sex difference of the metabolic disposition of clioquinol in rats.
    Ohshima N; Kotaki H; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1989 Jul; 12(7):371-7. PubMed ID: 2531797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal absorption and metabolism of clioquinol in the rat.
    Kotaki H; Yamamura Y; Tanimura Y; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1983 Nov; 6(11):881-7. PubMed ID: 6230438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The percutaneous absorption of topically applied tretinoin and its effect on endogenous concentrations of tretinoin and its metabolites after single doses or long-term use.
    Latriano L; Tzimas G; Wong F; Wills RJ
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 2):S37-46. PubMed ID: 9091507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous absorption and disposition of iodochlorhydroxyquin in dogs.
    Ezzedeen FW; Stohs SJ; Kilzer KL; Makoid MC; Ezzedeen NW
    J Pharm Sci; 1984 Oct; 73(10):1369-72. PubMed ID: 6239025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased protein-bound iodine in the serum from topical use of iodochloro-hydroxyquinoline ("Vioform").
    Boe E; Wereide K
    Acta Derm Venereol; 1970; 50(5):397-400. PubMed ID: 4099148
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A distinctive irritant contact reaction to Vioform (clioquinol).
    Beck MH; Wilkinson SM
    Contact Dermatitis; 1994 Jul; 31(1):54-5. PubMed ID: 7924302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.